Imatinib Mesylate
Who holds supplier records for Imatinib Mesylate? 24 organisations hold a current record for Imatinib Mesylate: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 17 of them hold a valid EU Certificate of Suitability (18 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (15), China (3), Italy (1), Netherlands (1) and 1 other country (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Imatinib Mesylate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/imatinib-mesylate
Reading the evidence
- 24 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
15 of the 21 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 19 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (24)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Imatinib Mesylate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- FIS FABBRICA ITALIANA SINTETICI SPAItalyCEP Company GMP cert on recordActive DMF 25205, 25206 · latest filing Jul 2011
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 26687, 25116, 30960 · latest filing Sept 2016
- Laurus Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 27089, 33312 · latest filing Nov 2018
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 26386, 32394 · latest filing Dec 2017
- SHILPA PHARMA LIFESCIENCES LTDIndiaCEPActive DMF 27927, 28349 · latest filing Jun 2014
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 34476, 30871 · latest filing Dec 2019
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 36238 · latest filing Aug 2021
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 26170, 28333 · latest filing Jun 2014
- Natco PharmaIndiaCEP Company GMP cert on recordActive DMF 20410 · latest filing Apr 2007
- Shandong Anxin Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 29656 · latest filing Aug 2015
- TAPI NL BVNetherlandsCEPActive DMF 21006 · latest filing Nov 2007
- Zhejiang Jiuzhou Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 23343 · latest filing Nov 2009
- ACEBRIGHT INDIA PHARMA PRIVATE LTDIndiaActive DMF 26322 · latest filing Aug 2012
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 24811 · latest filing Mar 2011
- Formosa Laboratories, Inc.Taiwan Company GMP cert on recordActive DMF 35153 · latest filing Oct 2020
- Reliance Life Sciences Pvt. Ltd.India Company GMP cert on recordActive DMF 24207 · latest filing Mar 2011
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 19499 · latest filing Jun 2006
- TAI HENG INDUSTRY GROUP CO LTDActive DMF 24838 · latest filing Mar 2011
- CDYMAX (INDIA) PHARMA PRIVATE LIMITEDIndiaCEP Company GMP cert on record
- Deva Holding AsCEP Company GMP cert on record
- Intas Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordInactive DMF 32270 · latest filing Nov 2017
- MAC CHEM PRODUCTS INDIA PVT LTDCEP
- SYNTHIMED LABS PRIVATE LIMITEDIndiaCEP Company GMP cert on record
- Zhejiang Ausun Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (18)
Certificates of Suitability on the EDQM register for Imatinib Mesylate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 29 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MAC-CHEM PRODUCTS (INDIA) PRIVATE LIMITED Mumbai | IN | CEP 2025-196 - Rev 00 Imatinib mesilate | Sept 2026 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2025-106 - Rev 01 Imatinib mesilate, FORM-β, ES Process | Sept 2026 | — |
| SHILPA PHARMA LIFESCIENCES LIMITED Raichur | IN | CEP 2026-126 - Rev 00 Imatinib mesilate, β-Form | Jul 2026 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2025-099 - Rev 00 Imatinib mesilate, β-Form | Nov 2025 | — |
| ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2023-303 - Rev 01 Imatinib mesilate, Form-β | Nov 2025 | Inspected Jan 2024 Hungary |
| LAURUS LABS LIMITED Hyderabad | IN | CEP 2020-086 - Rev 02 Imatinib mesilate, Process II | Sept 2025 | — |
| CDYMAX (INDIA) PHARMA PRIVATE LIMITED Bangalore | IN | CEP 2018-262 - Rev 02 Imatinib mesilate | Jul 2025 | Inspected Nov 2025 Switzerland |
| SHANDONG ANXIN PHARMACEUTICAL CO., LTD Jinan | CN | CEP 2017-292 - Rev 04 Imatinib mesilate, β form, milled, non-milled | Apr 2025 | Inspected Sept 2023 Austria, outside 3-year window |
| TAPI NL B.V. Amsterdam | NL | CEP 2015-096 - Rev 05 Imatinib mesilate | Feb 2025 | — |
| INTAS PHARMACEUTICALS LIMITED Ahmedabad | IN | CEP 2018-047 - Rev 03 Imatinib mesilate, β-form | Jan 2025 | — |
| Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Taizhou City | CN | CEP 2018-235 - Rev 02 Imatinib mesilate, Form α | Sept 2024 | Inspected Nov 2025 Hungary |
| SYNTHIMED LABS PRIVATE LIMITED Derabassi | IN | CEP 2021-151 - Rev 01 Imatinib mesilate, Form-α | Aug 2024 | Inspected Aug 2026 Slovenia |
| MSN LABORATORIES PRIVATE LIMITED Kardanur Village | IN | CEP 2017-118 - Rev 01 Imatinib mesilate | Mar 2024 | Inspected Aug 2026 Slovakia |
| DEVA HOLDING A.Ş. Istanbul | TR | CEP 2016-299 - Rev 01 Imatinib mesilate, α Form | Oct 2023 | — |
| NATCO PHARMA LIMITED Hyderabad | IN | CEP 2015-273 - Rev 01 Imatinib mesilate | Oct 2023 | — |
| F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio Maggiore | IT | R1-CEP 2016-058 - Rev 00 Imatinib mesilate | Aug 2022 | — |
| SHANDONG ANXIN PHARMACEUTICAL CO., LTD. Dongjia Town | CN | R1-CEP 2016-039 - Rev 00 Imatinib mesilate | Jun 2022 | — |
| CIPLA LIMITED Mumbai | IN | R1-CEP 2015-230 - Rev 00 Imatinib mesilate, Alpha form | May 2021 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (7)
Organisations whose Type II DMFs for Imatinib Mesylate are no longer active. These show a past filing, not current supply.
Show all 7 historical records
- SIGNA SA DE CVInactive DMF 28192 · filed Jun 2016
- Kyongbo Pharmaceutical Co., Ltd.South · Inactive DMF 28511 · filed Jul 2014
- India · Inactive DMF 27669 · filed Dec 2013
- China · Inactive DMF 26606 · filed Dec 2012
- Sichuan Xieli Pharmaceutical Co LtdChina · Inactive DMF 26362 · filed Aug 2012
- PHF SAInactive DMF 24287 · filed Dec 2010
- MYLAN LABORATORIES LTDInactive DMF 23139 · filed Oct 2009
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Imatinib Mesylate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1642).
Chemical identity
- IUPAC name
- methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
- Canonical SMILES
- CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O
- InChIKey
- YLMAHDNUQAMNNX-UHFFFAOYSA-N
- Synonyms
- Gleevec, Glivec, Imatinib accord, Imatinib actavis, Imatinib (as mesilate), Imatinib koanaa, Imatinib medac, Imatinib mesilate, Imatinib mesylate, Imatinib methane sulfonate, Imatinib methanesulfonate, Imatinib teva
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Kinase Inhibitor
- Mechanism of action
- Bcr-Abl Tyrosine Kinase Inhibitors; Cytochrome P450 2D6 Inhibitors; Cytochrome P450 3A4 Inhibitors; Protein Kinase Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Imatinib Mesylate?
24 organisations hold an active US FDA Type II Drug Master File or a CEP for Imatinib Mesylate: FIS FABBRICA ITALIANA SINTETICI SPA (Italy), Hetero Labs Limited (India), Laurus Labs Limited (India), MSN Laboratories Private Limited (India), SHILPA PHARMA LIFESCIENCES LTD (India), Zydus Lifesciences Limited (India), APITORIA PHARMA PRIVATE LTD (India) and Cipla Limited (India), and 16 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Imatinib Mesylate Drug Master Files are active?
FIS FABBRICA ITALIANA SINTETICI SPA (DMF 25205, 25206), Hetero Labs Limited (DMF 26687, 25116), Laurus Labs Limited (DMF 27089, 33312), MSN Laboratories Private Limited (DMF 26386, 32394), SHILPA PHARMA LIFESCIENCES LTD (DMF 27927, 28349), Zydus Lifesciences Limited (DMF 34476, 30871), APITORIA PHARMA PRIVATE LTD (DMF 36238) and Cipla Limited (DMF 26170, 28333) and 10 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Imatinib Mesylate records mean?
7 organisations have only inactive Type II DMFs for Imatinib Mesylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Imatinib Mesylate have a European Certificate of Suitability?
Yes. 17 organisations hold a valid CEP for Imatinib Mesylate on the EDQM register, including MAC-CHEM PRODUCTS (INDIA) PRIVATE LIMITED Mumbai (IN), HETERO LABS LIMITED Hyderabad (IN), SHILPA PHARMA LIFESCIENCES LIMITED Raichur (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. Taizhou (CN) and LAURUS LABS LIMITED Hyderabad (IN) and 12 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Imatinib Mesylate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Imatinib Mesylate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.